Case of both rivaroxaban- and dabigatran-induced leukocytoclastic vasculitis, during management of pulmonary thromboembolism

Russell, 2006, Primary cutaneous small vessel vasculitis: approach to diagnosis and treatment, Int. J. Dermatol., 45, 3, 10.1111/j.1365-4632.2005.02898.x Yao, 2016, Effectiveness and safety of dabigatran, rivaroxaban, and apixaban versus warfarin in nonvalvular atrial fibrillation, J. Am. Heart Assoc., 5, 10.1161/JAHA.116.003725 Gota, 2013, Diagnosis and treatment of cutaneous leukocytoclastic vasculitis, Int. J. Clin. Rheumatol., 8, 49, 10.2217/ijr.12.79 Cakiter, 2017, Demographic characteristics, aetiology, and assessment of treatment options in leukocytoclastic vasculitis, Adv. Dermatol. Allergol., 34, 104, 10.5114/ada.2017.67071 S. Basu, R. Mittal, Retinal vasculitis associated with cutaneous leukocytoclastic vasculitis. Int. Ophthalmol. https://doi.org/10.1007/s10792-017-0807-9. Poornimambaa, 2017, Utility of direct immunofluorescence in the diagnosis of small vessel vasculitis of the skin: a cross-sectional study, Indian Dermatol. Online J., 8, 515, 10.4103/idoj.IDOJ_298_16 Lath, 2018, Role of direct immunofluorescence in cutaneous small-vessel vasculitis: experience from a tertiary center, Am. J. Dermatopathol., 40, 661, 10.1097/DAD.0000000000001170 Minz, 2010, Direct immunofluorescence of skin biopsy: perspective of an immunopathologist, Indian J. Dermatol. Venereol. Leprol., 76, 150, 10.4103/0378-6323.60561 Alalwani, 2014, Clinical significance of immunoglobulin deposition in leukocytoclastic vasculitis: a 5-year retrospective study of 88 patients at Cleveland Clinic, Am. J. Dermatopathol., 36, 723, 10.1097/DAD.0000000000000122 Linskey, 2012, Immunoglobulin-A-associated small-vessel vasculitis: a 10-year experience at the Massachusetts general hospital, J. Am. Acad. Dermatol., 66, 813, 10.1016/j.jaad.2011.06.012 Al-Mutairi, 2008, Spectrum of cutaneous vasculitis in adult patients from the Farwaniya region of Kuwait, Med. Princ. Pract., 17, 43, 10.1159/000109589 Chaaya, 2016, Rivaroxaban-induced leukocytoclastic vasculitis. a challenging rash, Ann. Allergy Asthma Immunol., 116, 577, 10.1016/j.anai.2016.03.012 Hasbal, 2017, Leukocytoclastic vasculitis associated with a new anticoagulant: rivaroxaban, Turk. J. Hematol., 34, 116, 10.4274/tjh.2016.0353 Dean, 2017, A case of leukocytoclastic vasculitis caused by novel anticoagulant rivaroxaban, Dermatol. Online J., 15, 23 Christopoulou, 2017, Non-hemorrage-related adverse effects of rivaroxaban, Arch. Med. Sci. Atheroscler Dis., 31, e108, 10.5114/amsad.2017.72533 Sainz-Gaspar, 2018, Leukocytoclastic vasculitis associated with rivaroxaban, Int. J. Dermatol., 57, 622, 10.1111/ijd.13952 Cakmak, 2014, Adverse skin reaction caused by dabigatran, Eur. Rev. Med. Pharmacol. Sci., 18, 2595 Potolidis, 2015, Dabigatran associated leukocytoclastic vasculitis, Case Rep. Med., 2015, 616109, 10.1155/2015/616109 An, 2017, Dabigatran-related leukocytoclastic vasculitis, BMJ Case Rep., 2017